Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY 4.0Frontiers in Microbiology

EPS-producing Leuconostoc as probiotics: biomedical potential and structure–function perspectives

  1. 1Institute of Biochemistry and Biophysics, Polish Academy of Sciences
  2. 2Doctoral School of Molecular Biology and Biological Chemistry

Abstract

With the increasing prevalence of diseases associated with gut dysbiosis, such as gastrointestinal diseases, immunological disorders, metabolic and cardiovascular diseases, and cancer, there is a growing need for effective strategies to restore the gut microbiota and promote overall health. In this context, underexplored lactic acid bacteria, particularly those capable of producing exopolysaccharides (EPSs), are gaining attention due to the diverse and pleiotropic health benefits of their EPSs. This narrative review provides an overview of the health-promoting properties of Leuconostoc species and their associated EPSs, with particular emphasis on the structure–function relationships underlying EPS bioactivity. Furthermore, it examines the mechanisms through which EPS-producing Leuconostoc strains may influence gut and systemic health and discusses their potential as next-generation microbiome-based interventions. Notably, most available evidence is derived from in vitro and other preclinical models, while clinical studies directly validating the efficacy and health benefits of Leuconostoc EPSs in humans remain limited.

Related

  1. Whole genome sequences of four potential indigenous probiotics strains isolated from sediment of Sundarbans mangrove and wild black tiger shrimp (Penaeus monodon) from the Bay of Bengal, Bangladesh
    Shawon Ahmmed, Tahara Rohomania, Mohammad Shamsur Rahman
    Microbiology Resource AnnouncementsPeer-reviewedCC BY 4.0Full textImmunologyPMC
  2. The Screening and Identification of Potential Probiotics in Misgurnus anguillicaudatus Intestine
    Zhaoxin Sui, Mingshuai Shu, Ruining Zhang +4
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  3. Complete genome sequence of Enterococcus faecium strain GB_C_05 with potential characteristics applicable as a bacteriocin-producing probiotic feed additive.
    Juyoun Kang, Hyunok Doo, Jinok Kwak +8
    Journal of animal science and technologyPeer-reviewedCC BY-NCFull text2 citedGeneral biologyEurope PMC
  4. Producing biogas from energy cover crops in France: Potential production and agro-environmental impacts
    Camille Launay, Sabine Houot, Vincent Jean-Baptiste +2
    European Journal of AgronomyPeer-reviewedCC BY 4.0Full textGeneral biologyHAL
  5. Unveiling the potential of two different lactococcal glutamate decarboxylase enzymes and their application for producing GABA-rich soy beverages
    José Abellán, Pilar Sabuquillo, Raluca Elena Lazar +5
    Scientific ReportsPeer-reviewedCC BY 4.0Full textPlant biologyCrossref
BibTeX
@article{kopczynska2026epsproducing,
  title = {{EPS-producing Leuconostoc as probiotics: biomedical potential and structure–function perspectives}},
  author = {Julia Kopczyńska and Olha Kostiuchenko and Magdalena Kowalczyk},
  journal = {Frontiers in Microbiology},
  year = {2026},
  month = nov,
  doi = {10.3389/fmicb.2026.1912100},
  url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1912100/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - EPS-producing Leuconostoc as probiotics: biomedical potential and structure–function perspectives
AU  - Julia Kopczyńska
AU  - Olha Kostiuchenko
AU  - Magdalena Kowalczyk
PY  - 2026
DA  - 2026/11/10
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1912100
UR  - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1912100/full
AB  - With the increasing prevalence of diseases associated with gut dysbiosis, such as gastrointestinal diseases, immunological disorders, metabolic and cardiovascular diseases, and cancer, there is a growing need for effective strategies to restore the gut microbiota and promote overall health. In this context, underexplored lactic acid bacteria, particularly those capable of producing exopolysaccharides (EPSs), are gaining attention due to the diverse and pleiotropic health benefits of their EPSs. This narrative review provides an overview of the health-promoting properties of Leuconostoc species and their associated EPSs, with particular emphasis on the structure–function relationships underlying EPS bioactivity. Furthermore, it examines the mechanisms through which EPS-producing Leuconostoc strains may influence gut and systemic health and discusses their potential as next-generation microbiome-based interventions. Notably, most available evidence is derived from in vitro and other preclinical models, while clinical studies directly validating the efficacy and health benefits of Leuconostoc EPSs in humans remain limited.
SN  - 1664-302X
ER  -